What Is Cardiogenic Shock?
Cardiogenic shock (pump failure) is diminished cardiac output that severely impairs tissue perfusion. It reflects severe left-sided heart failure.
Pathophysiology
The myocardium can no longer contract hard enough to maintain output, so stroke volume drops and each beat ejects less blood. Blood backs up behind the weakened left ventricle, raising preload and congesting the lungs. Heart rate climbs to compensate, but the faster, weaker pump cuts coronary perfusion and collateral flow. Each step adds workload and deepens left-sided failure, driving myocardial hypoxia, further falling output, and, left unchecked, decompensation and death.
Classification
Causes are coronary or noncoronary. Coronary cardiogenic shock is the more common form and shows up most often after acute myocardial infarction. Noncoronary cardiogenic shock comes from conditions that stress the myocardium or leave it pumping ineffectively.
Statistics and Incidences
Cardiogenic shock is fatal if left untreated. It complicates roughly 5% to 10% of patients hospitalized with acute MI. Mortality historically ran 80% to 90%; with early revascularization, mechanical circulatory support, and modern critical care, contemporary in-hospital mortality is about 30% to 45%, and close to 40% of patients die within 30 days. It is more common in men than women because of their higher incidence of coronary artery disease.
Causes
Any condition causing significant left ventricular dysfunction with reduced cardiac output can trigger it. Myocardial infarction sets off compensatory mechanisms that prop up output briefly, then give way to deterioration. Myocardial ischemia does the same as oxygen demand rises on an already compromised myocardium. End-stage cardiomyopathy leaves the heart unable to pump enough blood for the body's needs.
Clinical Manifestations
Everything you see points to poor tissue perfusion. Skin is cool and clammy. Systolic blood pressure falls to 30 mmHg below baseline. The heart races (tachycardia) to compensate for low output. Respirations are rapid and shallow. Urine output under 20 mL/hour signals oliguria. Too little oxygenated blood to the brain brings mental confusion and obtundation, and cyanosis appears as oxygen delivery fails across the body.
Assessment and Diagnostic Findings
Auscultation may pick up a gallop rhythm, faint heart sounds, and, if shock follows rupture of the ventricular septum or papillary muscles, a holosystolic murmur. Pulmonary artery pressure (PAP) monitoring shows rising PAP, reflecting higher left ventricular end-diastolic pressure and resistance to afterload. Invasive arterial pressure monitoring shows hypotension from impaired ventricular ejection. ABG analysis shows metabolic acidosis and hypoxia. Electrocardiography may reveal acute MI, ischemia, or ventricular aneurysm. Echocardiography assesses left ventricular function and reveals valvular abnormalities. Enzyme levels (lactic dehydrogenase, creatine kinase, aspartate aminotransferase, and alanine aminotransferase) may confirm MI.
Medical Management
Treatment aims to restore cardiovascular status. Give oxygen to limit damage to muscle and organs. Angioplasty and stenting open the blocked artery. A balloon pump in the aorta supports blood flow and unloads the heart. Give IV morphine for chest pain. An arterial line allows accurate, continuous BP monitoring and a port for frequent arterial blood samples. Give fluids carefully and watch for signs of overload.
Pharmacologic Therapy
IV dopamine, a vasopressor, raises cardiac output, blood pressure, and renal blood flow. IV dobutamine is an inotrope that boosts myocardial contractility. Norepinephrine is a more potent vasoconstrictor used when needed. IV nitroprusside is a vasodilator paired with a vasopressor to improve output by dropping peripheral vascular resistance and reducing preload.
Surgical Management
When drug therapy and medical procedures fail, surgery is the last option. The intra-aortic balloon pump (IABP) is a mechanical-assist device inserted percutaneously or surgically through the femoral artery into the descending thoracic aorta; its inflatable balloon improves coronary artery perfusion and lowers cardiac workload.
Frequently Asked Questions
What is cardiogenic shock? It is pump failure: the heart, most often the left ventricle, can no longer move enough blood to perfuse the body. Cardiac output and tissue perfusion fall together, and the patient deteriorates quickly without treatment.
What is the most common cause of cardiogenic shock? Acute myocardial infarction. Cardiogenic shock complicates roughly 5% to 10% of patients hospitalized with an MI, usually from large left-ventricular damage. Noncoronary causes include end-stage cardiomyopathy, severe valve disease, and myocarditis.
How is cardiogenic shock different from hypovolemic shock? Both drop cardiac output, but the problem differs. Hypovolemic shock is a volume problem (the tank is empty), so fluids help. Cardiogenic shock is a pump problem, so aggressive fluids can flood the lungs; care centers on inotropes, vasopressors, and mechanical support instead.
What are the early warning signs at the bedside? Cool, clammy skin, a systolic pressure falling toward 30 mmHg below baseline, tachycardia, rapid shallow breathing, urine output under 20 mL per hour, and new confusion. These point to failing perfusion and call for rapid escalation.
What is the survival rate for cardiogenic shock? It remains serious. Mortality once ran 80% to 90%, but with early revascularization, mechanical circulatory support, and modern critical care, contemporary in-hospital mortality is about 30% to 45%. Early recognition and reperfusion improve the odds.